Hepatitis C virus (HCV) is a leading cause of chronic blood-borne infection and chronic liver
disease. The global epidemic of HCV infection emerged in the second half of the 20th
century, and several lines of evidence indicate that it was primarily triggered and fed
iatrogenically by the increasing use of parenteral therapies and blood transfusion. In
developed countries, the rapid improvement of healthcare conditions and the introduction of
anti-HCV screening for blood donors have led to a sharp decrease in the incidence of …